Recombinant CCR5 (Leronlimab Biosimilar) 抗体
This Mammalian Cells 单克隆 antibody specifically detects CCR5 (Leronlimab Biosimilar) in ELISA. It exhibits reactivity toward 人.
产品编号 ABIN7488173
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CCR5 (Leronlimab Biosimilar) 抗体 (ABIN7488173)
抗原
CCR5 (Leronlimab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This CCR5 (Leronlimab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Leronlimab Biosimilar - Anti-CCR5, CD195 mAb
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CCR5 (Leronlimab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
HuPRO-140,PA-14,PRO-140
Leronlimab, a monoclonal antibody blocker of C-C chemokine receptor type 5 originally developed to treat human immunodeficiency virus infection, was administered as an open-label compassionate-use therapeutic for coronavirus disease 2019 (COVID-19). -
CAS-编号
- 674782-26-4
抗原
-
You are here:
